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As DNA damage induced by ultraviolet radiation
plays an essential role in skin cancer induction, we
pursued the measure of several DNA lesions induced
by ultraviolet radiation in human skin for determin-
ing the ef®cacy of different topical photoprotectors.
Non-exposed skin (buttocks from 20 individuals) was
exposed to 10 doses of ultraviolet, which corres-
ponded to three to four minimal erythema doses of
solar-simulating radiation, and biopsies were taken
at 24 h within the half and one minimal erythema
dose sites and a nonirradiated, adjacent control area.
We report that even suberythemal doses of ultravio-
let radiation are capable of inducing substantial DNA
damage, namely pyrimidine dimers, p53 induction,
and the DNA base-modi®ed product generated by
oxidative stress, 8-hydroxy-2¢-deoxyguanosine. All
three lesions are induced in a dose-dependent man-
ner. An additional eight individuals were treated
with either ultraviolet B or ultraviolet B + ultraviolet
A sunblock (sun protection factor 15) and exposed to
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and 15 times the minimal erythema dose on
each individual, with biopsies taken at 24 h post-
ultraviolet. Pyrimidine dimer and p53 expression
were rarely seen in nonirradiated skin but occasional
staining was seen in all normal skin for 8-hydroxy-
2¢-deoxyguanosine. Applications of sunscreens to
human skin before irradiation were shown to attenu-
ate erythema but did not completely eliminate all
three types of cellular damage when tested up to
their sun protection factor 15. Furthermore, ultra-
violet B + ultraviolet A sunscreens were less ef®cient
than the ultraviolet B alone formulation for protec-
tion against all three lesions. These results suggest
that DNA damage assessed in vivo by immunohisto-
chemistry provides a very sensitive endpoint for
determining the ef®cacy or photosensitivity of pos-
sible different protective measures in human skin.
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unscreens by de®nition are topical preparations that
reduce penetration of damaging solar ultraviolet (UV)
wavelengths. Ideally, sunscreens should prevent acute and
chronic actinic damage of sun exposure by delaying
photoaging and preventing carcinomas and even mela-
noma induction.
Sunscreen preparations are generally assessed for their ability to
protect against erythema formation. Their sun protection factor
(SPF) indicates the number of minimal erythema doses a given
individual can tolerate before an erythema occurs on the protected
site. As the relationship of erythema to skin cancer induction is not
obvious, it was recently suggested that other earlier end points are
perhaps more accurate predictors of sunscreen effectiveness from
cancer (Ananthaswamy et al, 1999). In this respect, mutation of the
p53 tumor suppressor gene was proposed as a short-term marker for
skin cancer development as it takes 1 mo to occur. It was also stated
by the same authors that the inhibition of p53 mutation by
sunscreens is most probably due to their protection against UV-
induced DNA damage. This indeed seems logical as p53 mutations
occur most probably at pyrimidine dimer sites. We have previously
shown, when using a highly sensitive immunohistochemical
technique, that both pyrimidine dimers and p53 are induced in
human skin following UVB and UVA radiations (Applegate et al,
1997) even following suberythemal doses (Hall et al, 1993; Barnadas
et al, 1996). Pyrimidine dimers alter the biologic functions of DNA
and they have been shown to be a major cause of lethal and
mutagenic (Harm, 1976), tumorigenic (Hart et al, 1977), and
transformational (Sutherland et al, 1985) events. More speci®cally in
human and other mammalian skin, pyrimidine dimers have been
shown to be involved in many, thought to be detrimental,
pathways including erythema (van Weelden, 1984; Ley, 1985),
edema, keratinocyte damage (sunburn cell formation) (Ley and
Applegate, 1985; 1987), suppressed immunity (Applegate et al,
1989), and tumor formation (Ley et al, 1991; VandeBerg et al,
1994). These lesions have readily been shown to be present using
immunohistochemistry techniques with peak protein expression at
18±24 h. Interestingly, many of the lesions remain at 48 h and even
up to several weeks post-UV (Young et al, 1996; Applegate et al,
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1997; Ahmed et al, 1999). Therefore, it is well established that UV
radiation induces DNA damage, which has been shown to be
responsible for a variety of negative effects in human skin.
Another lesion that can be induced by the generation of reactive
oxygen species from ultraviolet radiation is the mutation-prone
DNA base-modi®ed product 8-hydroxy-2¢-deoxyguanosine (8-
OHdG). These lesions can be readily induced in human skin
following UVB radiation and are still present in part 24 h
postirradiation (Ahmed et al, 1999). We have also seen that high
levels of 8-OHdG can be induced by UVA I and UVA I + II
irradiation of human skin (unpublished results). Transversions of
GC to TA have been demonstrated in the p53 and ras genes in
UVB-induced skin tumors in human nonmelanoma skin cancer
(Van der Schroeff et al, 1990). A high percentage of these GC to
TA transversions in human skin tumors have been associated with
the formation of 8-OHdG by UVA-generated reactive oxygen
species (Daya-Grosjean et al, 1995).
By assessing the initial damage of DNA such as pyrimidine dimer
formation (CC®TT) along with the expression of p53 protein and
8-OHdG following UV irradiation in sunscreen-protected human
skin, it would be possible to provide sensitive biologic endpoints
that could be used to evaluate sunscreen formulations (ef®ciency or
possible photosensitization) targeted for UVB alone or for total
block protection of UV in human skin.
MATERIALS AND METHODS
Volunteers A total of 28 healthy volunteers between the ages of 20
and 45 y with skin types II±III were used in these studies. Delimited
areas of the buttocks were subjected to 10 increasing doses of UV
radiation and the erythema and melanin reactions were measured at 24 h
post-UV on each site along with two control unirradiated sites
(Dermaspectrometer). In eight volunteers where sunscreen preparations
were used, both UVB and UVB + UVA sunscreens were applied to
delimited sites (2 mg per cm2) at least 15 min prior to UV exposure.
Biopsies of 4 mm were taken under local anesthesia (1% lidocaine) 24 h
after the UV exposure to 1
2
and 1 minimal erythema dose (MED) and
from an adjacent nonirradiated control site. A total of six biopsies were
taken from each of the 28 volunteers as approved by the Hospital Ethics
Committee.
For frozen sections, one half of each biopsy was immediately placed in
a beaker with isopentane-2-methyl-butane chilled in liquid nitrogen for
2 min. Thereafter, the tissue was transferred to liquid nitrogen for storage
until serial frozen sections of 5 mm could be prepared. The other half of
each biopsy was placed in formalin for ®xation and paraf®n embedded
for subsequent 5 mm serial sections.
Radiation sources and exposure conditions A 15S single port Solar
UV Simulator ®ltered with Schott WG320/1 mm and UG 11/1 mm
®lters (290±400 nm) emitting energy similar to that of the overhead sun
up to 400 nm was used at a dose rate of approximately 108 MED per h,
extrapolated by the manufacturer to be 13±16 W per m2 (Solar Light,
Philadelphia, PA) as indicated by the manufacturer. Radiation exposure
(intensity and dose) was continuously controlled by a Dose Control
System (Solar Light) directly attached to the 15S Solar Simulator, which
automatically operates a shutter system that closes for a preset dose.
Irradiation periods were of approximately 30±60 s duration (without
sunscreen preparations) to obtain an MED on type II±III skin.
Sunscreen preparations Sunscreens with SPF 15 for UVB only or
UVB + UVA absorbers were provided by Givaudan (Geneva) and are
similar to many formulations that are available on the market today. Oil
in water emulsions containing Parsol MCX (8%) and Eusolex (2%) were
used for the UVB only preparation and Uvinul (9%), Eusolex (0.3%),
Mexoryl (0.7%) and Parsol 1789 (3%) for the UVB + UVA sunscreen
preparation.
Immunohistochemistry Frozen sections (pyrimidine dimers) and
®xed tissue sections (p53 and 8-OHdG) of 5 mm thickness were used for
the immunohistochemistry. All incubations were done in a humidi®ed
chamber in the dark unless otherwise speci®ed.
For detection of pyrimidine dimers, frozen sections were subjected to
a mild alkaline hydrolysis (0.7 N NaOH for 4 min) followed by
digestion with proteinase K (1 mg per ml for 10 min).
For detection of 8-OHdG, tissue sections were treated with a Target
Retrieval Solution (Dako, Zug, Switzerland) in a 95°C water bath
followed by a 20 min cooling period and all washings were with Tris-
buffered saline with Tween (TBST) at 95°C.
For both frozen and ®xed tissue, the sections were ®xed with 4%
paraformaldehyde for 30 min at 25°C and washed with phosphate-
buffered saline (PBS)/TBST three times for 10 min each. Tissue sections
were incubated with 0.1% phenylhydrazine in PBS for 60 min at 37°C
to block endogenous peroxidases and washed twice for 5 min each. This
blocking step was accomplished with the Dako blocking system for 8-
OHdG and was followed by an ampli®cation with a Dako catalyzed
signal ampli®cation system as suggested by the supplier. The antibody
was from the Japan Institute for the Control of Aging and was diluted at
1:20,0000 with Dako antibody diluent with background-reducing
components incorporated.
For p53 and dimers, nonspeci®c binding was blocked by an incubation
for 2 h at 25°C with a solution of PBS containing 5% fetal bovine serum
(FBS), 7% normal goat serum (NGS), and 0.1% Triton X 100. Tissue
sections were then incubated overnight at 4°C with H3 monoclonal
speci®c antibodies against thymine dimers (provided by Dr. Len Roza,
TNO, The Netherlands) at a 1:50 dilution in PBS containing 5% FBS,
5% NGS, and 0.1% Triton X 100, or for 30 min with DO7 antibodies
against wildtype p53 protein (Dako). For control samples, the primary
antibodies were replaced with a nonspeci®c IgG antibody. Immediately
following this incubation (p53) or the following morning (pyrimidine
dimers), tissue sections were washed three times for 10 min each in PBS
and treated with biotinylated goat antirabbit antibody at 1:200 in a
solution of PBS with 5% FBS, 1% NGS, and 0.1% Triton X 100 for 3 h
at 25°C. Tissue sections were washed four times for 5 min each in PBS
and then treated with Vectastain ABC (Vector, Burlingame, CA) as
indicated by the company for 3 h at 25°C. After this incubation, tissue
sections were washed three times for 10 min each in PBS and treated
with 0.5 mg per ml 3,3¢-diaminobenzidine with 0.32 ml of 30% H2O2
added just before an incubation of 1±2 min. All samples were treated at
the same time. Control samples were included with each experiment,
using negative control reagents that were routinely applied to histologic
sections of each control and test specimen to avoid nonspeci®c interpret-
ation. The primary antibody was replaced with an isotype IgG. The
antibody staining for thymine dimers, p53, or 8-OHdG is represented by
the brown coloration. The samples were washed for 5 min under
running water. They were counterstained with Papanicolaou (Harris's
Haematoxylin solution), dehydrated, and mounted with Merckoglas
(Merck, Switzerland).
Video image analysis of immunohistochemical treated
skin Sections stained for each antibody were analyzed with a Leica
DC100 video imaging system (offered by SPIRIG, Switzerland). For
each experiment, four histologic sections were stained by each antibody
Figure 1. Induction of erythema in UV-irradiated human skin.
Erythema was measured by a dermaspectrometer on irradiated buttock
sites of 28 individuals. The erythema was reported in arbitrary units once
the background coloration was subtracted for each individual. Points are
an average of 10 irradiation sites on each of 28 individuals with the
associated standard deviation of the mean.
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and used only on analysis and sections without counterstaining. Six
regions from each section were selected and the intensity of staining for a
total area was measured and quanti®ed by the analysis program designed
for these studies. The frank quanti®cation of dimers and 8-OHdG was not
determined because of the treatments necessary to permeabilize cells for
staining. The antigen retrieval can damage the normal histology of the
section and more frequent holes are seen in the tissue sections than in
paraf®n-embedded samples. Therefore we semiquanti®ed these results
from visual assessment on a scale of ± (no to very little staining) to ++++
for increasing staining intensity with the aid of video image analysis. We
could successfully quantify p53 from paraf®n-embedded tissues and stained
nuclei were counted for a total of 1000 cells. Results are reported as the
number of p53-positive nuclei for 1000 cells.
RESULTS
Erythema induction and protection by sunscreens In all 28
individuals, there was a dose-dependent increase in erythema and
the tested MED varied from 20 to 35 mJ per cm2 (Fig 1). Both
UVB and UVB + UVA sunscreen preparations (SPF 15) were able
to protect against erythema induction in all individuals irradiated
with 7.5 MED and in ®ve of the eight individuals following 15
MED. Three individuals had a slight, uneven erythema in the 15
MED irradiated sites (one in the UVB alone group and two in the
UVB + UVA sunscreen group).
Pyrimidine dimer, p53, and 8-OHdG expression in human
skin following UV irradiation Eight individuals were
irradiated with the Solar Light Simulator at doses of 0, 1
2
, and 1
MED (four for pyrimidine dimers and four for p53 and 8-OHdG).
In all individuals, there was no expression of pyrimidine dimers in
nonirradiated skin. Following increasing doses of UV radiation
there was a concomitant augmentation of pyrimidine dimer
induction (Fig 2). Even following suberythemal UV doses,
approximately 25%±45% of the epidermal cells showed staining
for pyrimidine dimers in any given individual tested.
For p53, all unirradiated biopsies from individuals showed an
occasional one to four stained nuclei for 1000 cells and likewise, as
with pyrimidine dimer induction, p53 stained epidermal cells
increased concomitantly with higher doses of UV radiation (Fig 2).
Suberythemal doses of UV also showed already signi®cant increases
Figure 2. Induction of pyrimidine dimers, p53, and 8-OHdG in UV-irradiated human skin in situ. Pyrimidine dimers, p53, and 8-OHdG
expression were assessed by enhanced avidin±biotin immunohistochemical methods in skin irradiated with 0, 1
2
, and 1 MED of solar simulator radiation
(Solar Light Simulator) and in skin treated with UVB or UVB + UVA sunscreen preparations and exposed to 7.5 and 15 times the MED of each
individual. Scale bar: 40 mm.
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in p53 epidermal staining (Fig 2). All individuals showed some
staining for 8-OHdG in normal skin and staining of epidermal cells
increased in a dose-dependent manner following UV radiation.
Maximal levels of 8-OHdG were seen at 1
2
MED doses whereas
there was a continued increase in nuclear staining for both p53 and
dimers at 1 MED.
Differential protection of UVB and UVB + UVA sunscreen
preparations against pyrimidine dimers, p53, and 8-OHdG
expression in UV- irradiated human skin Both sunscreen
preparations showed good protection against erythema even after
the 15 MED exposure and there was measurable damage in all
protected skin for pyrimidine dimers, p53, and 8-OHdG.
The preparations were effective in reducing the number of cells
stained for pyrimidine dimers and 8-OHdG to a level of damage
similar to that induced by 1
2
to 1 MED with no protection (Table I,
Fig 3). The quanti®cation of dimers and of 8-OHdG is rendered
dif®cult because of the treatment of the tissue to have access to the
antibody sites. The UVB and UVB + UVA sunscreen protected
skin revealed damage comparable to that observed in nonprotected
skin irradiated with 1
2
to 1 MED for 7.5 and 15 MED, respectively
(Fig 3).
Skin samples stained for p53 could be quanti®ed using the video
imaging analysis microscope. A total of 1000 cells were counted for
each biopsy and the number of p53-positive nuclei was assessed.
There was a dose-dependent increase in p53 staining. The UVB
sunscreen preparation showed protection of damage that would
normally be induced by 1 MED without protection (Fig 3). The
UVB + UVA preparation showed protection against p53 induc-
tion following 7.5 and 15 MED doses of UV where damage was
similar to nonprotected sites at 1 MED.
DISCUSSION
Skin carcinogenesis depends strongly on DNA repair systems
available to excise DNA lesions. Excision repair can remove the
pyrimidine dimer and some adjacent nucleotides, and the integrity
of the DNA molecule is restored through repair synthesis. Excision
repair has been reported to occur in the epidermis of marsupials and
humans whereas mouse and rat cells have no or markedly lower
rates of excision repair (Ley et al, 1977; Vijg et al, 1984; Applegate
and Ley, 1987). This perhaps is an important aspect when using the
mouse model for carcinogenesis (Ananthaswamy et al, 1997) or
assessing chronically accumulated damage in rodent tissue.
In general, it is agreed that the initial step in UV carcinogenesis is
damage to the DNA molecule and this can be assessed to a high
degree of sensitivity in human skin in vivo. Pyrimidine dimers, p53,
and 8-OHdG have been shown to be induced by UVA I, UVA
I + II, and solar simulating radiation and therefore are interesting
markers for assessing protective measures in human skin.
Protection against acute sunburn is well substantiated by
extensive human experience. The development of other short-
term markers for SPF testing are those shown to be involved in
carcinogenesis (as this endpoint would be impossible to test in
humans). Several studies in human skin show that sunscreens
protect against DNA damage in UV-exposed human skin by
reducing pyrimidine dimers and 6±4 photoproducts and also the
induction of p53 (Freeman et al, 1988; Van Praag et al, 1993;
Ponten et al, 1995; Ananthaswamy et al, 1997; Bykov et al, 1998).
In addition, markers for photo-immunosuppression and photoaging
have also been tested with various protocols and with various
degrees of success. Unfortunately, many of the testing procedures
did not test an SPF 15 cream with 15 times the dose of UV to
induce an erythema and therefore the full possibilities of protection
were not truly exploited (Beasley et al, 1998; Berne et al, 1998).
We have chosen to assess several lesions detectable in DNA
following oxidative stress that have been induced following both
UVB and UVA radiation in human skin. The observed inferior
protection in human skin obtained with the UVB + UVA
sunscreen compared to that with the UVB sunscreen is interesting.
Whether this is due to some chemical interaction causing a
sensitivity increase or the possibility that UVA radiation enhances
the protection capacity of human skin is not known.
Photosensitivity of many sunscreen components is well known
(Kaidbey and Kligman, 1978; Sutherland and Griffen, 1984;
Thune, 1984) and this important possibility cannot be eliminated
at present. It has also been shown, however, that UVA radiation
and/or visible light can attenuate certain damage induced by UVB
in human skin. It could therefore be possible that, because these
wavelengths are prevented with sunscreen protection, more
damage is permitted in human skin. This possibility is supported
by several studies where UVB-induced erythema in human skin
was decreased by a combination of UVA radiation (van Weelden
et al, 1984); moreover, UVB-induced thymine dimers were
decreased when human skin was exposed to UVA and/or visible
light (Sutherland et al, 1980; D'Ambrosio et al, 1981; Eggset et al,
1983; Roza et al, 1991).
Figure 3. Quantity of p53 protein induction in UV-irradiated
human skin and the degree of protection provided by UVB and
UVB + UVA sunscreens. p53 expression was assessed by enhanced
avidin±biotin immunohistochemical methods in biopsies at 24 h in skin
exposed to 0, 1
2
, and 1 MED and in sunscreen-protected skin (UVB
alone and UVB + UVA cream preparations) following 7.5 and 15 MED
from the Solar Light Simulator (dose 1
2
and 1, respectively). Expression of
p53 in human skin assessed by the number of p53-positive cells for 1000
cells counted as a function of dose of UV radiation from the Solar Light
and Oriel Solar Simulators. Data points are an average of eight
individuals for no protection (h) and for the sunscreen preparations
UVB alone sunscreen (D) and UVB + UVA sunscreen (s) with
associated standard deviations of the mean.
Table I. Induction of pyrimidine dimers, p53, and 8-OHdG
in human skin by UV radiation and the protection
provided by topical sunscreens (UVB only versus
UVB + UVA formulations)
Treatment Dimers 8-OHdG
MED
0 ± 6
1
2
+6 ++6
1 +++ ++++
UVB sunscreen
7.5 ++6 ++6
15 +++ +++
UVB + UVA sunscreen
7.5 +++ +++
15 +++ ++++
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In our study, we have seen that high levels of DNA damage can
be induced even without the ®rst warning of an erythema present.
Does this mean that sunscreens offer false safety? They do prevent
actinic erythema but they do not seem to prevent all effects of UV.
DNA lesions can be induced at very high rates even in protected
skin and these lesions represent an initial indicator for carcinogenic
pathways. New generations of sunscreens are available (i.e.,
Tinosorb M, methylene-bis-benzotriazolyl-tetramethyl-butylphe-
nol; and Tinosorb S, bis-thylhexyloxyphenol-methoxyphenyl-
triazine) that cover both the UVB and UVA spectrum with just
one active ingredient. New technologies for both chemical and
physical protection should aim to eliminate direct and oxidative
DNA damage.
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